Understanding how Epstein-Barr Virus affects Multiple Sclerosis
Defining the Role of Epstein-Barr Virus in Multiple Sclerosis
['FUNDING_OTHER'] · STANFORD UNIVERSITY · NIH-11062472
This study is looking at how the Epstein-Barr Virus might be linked to Multiple Sclerosis, and it’s for people with MS who want to help us understand how this virus could affect their condition and treatment by sharing their samples and information.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | STANFORD UNIVERSITY (nih funded) |
| Locations | 1 site (STANFORD, UNITED STATES) |
| Trial ID | NIH-11062472 on ClinicalTrials.gov |
What this research studies
This research investigates the connection between Epstein-Barr Virus (EBV) infection and the development of Multiple Sclerosis (MS), a condition that causes significant disability in young adults. The study will analyze the presence and levels of antibodies against various EBV proteins in large patient groups to understand their role in MS progression and treatment response. By exploring molecular mimicry between EBV and specific proteins in the nervous system, the research aims to uncover critical mechanisms that may contribute to MS. Patients will be involved in providing samples and data to help clarify these relationships.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Multiple Sclerosis, particularly those who have a history of Epstein-Barr Virus infection.
Not a fit: Patients who do not have Multiple Sclerosis or have not been infected with Epstein-Barr Virus may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights into the causes of Multiple Sclerosis and potentially improve treatment strategies for patients.
How similar studies have performed: Previous research has indicated a potential link between Epstein-Barr Virus and Multiple Sclerosis, suggesting that this approach may yield valuable insights.
Where this research is happening
STANFORD, UNITED STATES
- STANFORD UNIVERSITY — STANFORD, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SATTARNEZHAD OSKOUEI, NEDA — STANFORD UNIVERSITY
- Study coordinator: SATTARNEZHAD OSKOUEI, NEDA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: autoimmune disease in the nervous system, Autoimmune Diseases